Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Medical Transcription Billing Corp Company Profile (NASDAQ:MTBC)

Consensus Ratings for Medical Transcription Billing Corp (NASDAQ:MTBC) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.63 (245.02% upside)

Analysts' Ratings History for Medical Transcription Billing Corp (NASDAQ:MTBC)
Show:
DateFirmActionRatingPrice TargetDetailsShare
2/23/2015Chardan CapitalInitiated CoverageBuy$11.00 -> $6.25ViewTweet This Rating  Share This Rating on StockTwits
9/3/2014Summer StreetInitiated CoverageBuy$9.00ViewTweet This Rating  Share This Rating on StockTwits
8/13/2014Chardan CapitalInitiated CoverageBuy$11.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/29/2013 forward)